(Q42498205)

1 November 2017

title

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants (English)

1 reference

1 November 2017

A Garcia-Lora

1

1 reference

1 November 2017

I Algarra

2

1 reference

1 November 2017

J J Gaforio

3

1 reference

1 November 2017

F Ruiz-Cabello

4

1 reference

1 November 2017

F Garrido

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

International Journal of Cancer

1 November 2017

published in

1 reference

1 November 2017

volume

91

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

109-119

1 reference

Identification of human cancers deficient in antigen processing

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Host MHC class I gene control of NK-cell specificity in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

A new beta 2 microglobulin mutation found in a melanoma tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

The HLA crossroad in tumor immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Receptors for HLA class-I molecules in human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: a D/L hybrid gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Antitumor immunity at work in a melanoma patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

The Susceptibility to Cytotoxic T Lymphocyte Mediated Lysis of Chemically Induced Sarcomas from Immunodeficient and Normal Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

The great escape: Is immune evasion required for tumor progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

HLA and cancer: from research to clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Strain- and age-dependent natural and activatedin vitrocytotoxicity in athymicnudemice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

MCA Sarcomas Induced in scid Mice are More Immunogenic than MCA Sarcomas Induced in Congenic, Immunocompetent Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Locus-specific de novo methylation down-regulates MHC class I in S49 lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

Alpha1/alpha2 domains of H-2D(d), but not H-2L(d), induce "missing self" reactivity in vivo--no effect of H-2L(d) on protection against NK cells expressing the inhibitory receptor Ly49G2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010101%2991%3A1%3C109%3A%3AAID-IJC1017%3E3.0.CO%3B2-E

10.1002/1097-0215(20010101)91:1<109::AID-IJC1017>3.0.CO;2-E

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference